N,N-Dimethyl-4-methylthioamphetamine
Chemical compound
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
N,N-Dimethyl-4-methylthioamphetamine (also known as 4-MTA) is a synthetic amphetamine derivative. It is a member of the thioamphetamine class of compounds, which are characterized by the presence of a sulfur atom in the para position of the phenyl ring. This compound is known for its psychoactive properties and has been studied for its effects on the central nervous system.
Chemical Structure and Properties[edit]
N,N-Dimethyl-4-methylthioamphetamine is structurally related to amphetamine, with the addition of a methylthio group at the para position of the phenyl ring and two methyl groups attached to the nitrogen atom. The presence of the sulfur atom in the para position is a distinguishing feature of this compound, which influences its pharmacological activity.
Pharmacology[edit]
The pharmacological effects of N,N-Dimethyl-4-methylthioamphetamine are primarily due to its action as a serotonin releasing agent. It has been shown to increase the release of serotonin in the brain, leading to its psychoactive effects. The compound has been associated with stimulant and empathogenic effects, similar to those of other amphetamine derivatives.
Effects and Risks[edit]
The use of N,N-Dimethyl-4-methylthioamphetamine can lead to a range of effects, including increased energy, euphoria, and altered perception. However, it also carries significant risks, including neurotoxicity, cardiovascular complications, and potential for addiction. The compound has been associated with several adverse effects, including hyperthermia, hypertension, and tachycardia.
Legal Status[edit]
Due to its potential for abuse and harmful effects, N,N-Dimethyl-4-methylthioamphetamine is classified as a controlled substance in many countries. It is illegal to manufacture, possess, or distribute this compound without proper authorization.
Synthesis[edit]
The synthesis of N,N-Dimethyl-4-methylthioamphetamine involves the introduction of a methylthio group to the para position of the phenyl ring of amphetamine, followed by N,N-dimethylation. The process requires careful handling of reagents and conditions to ensure the desired product is obtained.
Related Compounds[edit]
N,N-Dimethyl-4-methylthioamphetamine is related to other thioamphetamine derivatives, such as 4-MTA and 4-Methylthioamphetamine (4-MTA). These compounds share similar structural features and pharmacological properties.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian